businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 223
 

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Marina Biotech, Inc. Closes Previously Announced $5 Million Financing

BOTHELL, WA: Financing Provides Flexibility to Execute on Pre-Clinical, Clinical and Partnering Objectives ...

Cerecor to Present at Biotech Showcase 2012 in San Francisco

BALTIMORE, MD: Company to Present Overview and Update on Development Milestones ...

The Alliance for Regenerative Medicine Announces Agenda for Regenerative Medicine Insight Track at Biotech Showcase on January 10 and 11 in San Francisco

WASHINGTON, DC: Speakers Include Advanced Cell Technology, Athersys, Cytori, Dendreon, Genzyme-Sanofi, Johnson & Johnson, Mesoblast, and Shire ...

ISTA Pharmaceuticals Announces Preliminary 2011 Revenue Results; Provides 2012 Financial Guidance and Updates Key Pipeline Milestones

IRVINE, CA: Expects Profitability in 2011 for the Second Consecutive Year on an Adjusted Cash Net Income Basis Unaudited 2011 Net Revenues Expected to Be Greater Than $160 Million 2012 Net Revenues Expected to Gr ...

FDA Approval to Commence Huntington's Disease Clinical Trial Using Prana's PBT2

MELBOURNE, AUSTRALIA: Huntington Study Group Appointed to Coordinate the Trial and Start Recruitment ...

ISTA Pharmaceuticals to Present at the 14th Annual Needham Growth Conference

IRVINE, CA: ISTA Reminds Investors of Its Upcoming 2012 Guidance and Pipeline Update Webcast/Conference Call Scheduled on January 4, 2012 ...

Marina Biotech, Inc. to Present at Biotech Showcase 2012

BOTHELL, WA: Company Will Update on Recent Licensing Transaction and Near-Term Value Drivers ...


Page 223 von 247:  « ..  222 223 224  225  226  227  228  229  230  231  .. » 247





 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 94


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.